Cargando…
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study
OBJECTIVES: To investigate serological differences between SARS-CoV-2 reinfection cases and contemporary controls, to identify antibody correlates of protection against reinfection. METHODS: We performed a case-control study, comparing reinfection cases with singly infected individuals pre-vaccinati...
Autores principales: | Atti, Ana, Insalata, Ferdinando, Carr, Edward J, Otter, Ashley D, Castillo-Olivares, Javier, Wu, Mary, Harvey, Ruth, Howell, Michael, Chan, Andrew, Lyall, Jonathan, Temperton, Nigel, Cantoni, Diego, da Costa, Kelly, Nadesalingam, Angalee, Taylor-Kerr, Andrew, Hettiarachchi, Nipunadi, Tranquillini, Caio, Hewson, Jacqueline, Cole, Michelle J, Foulkes, Sarah, Munro, Katie, Monk, Edward J M, Milligan, Iain D, Linley, Ezra, Chand, Meera A, Brown, Colin S, Islam, Jasmin, Semper, Amanda, Charlett, Andre, Heeney, Jonathan L, Beale, Rupert, Zambon, Maria, Hopkins, Susan, Brooks, Tim, Hall, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458758/ https://www.ncbi.nlm.nih.gov/pubmed/36089104 http://dx.doi.org/10.1016/j.jinf.2022.09.004 |
Ejemplares similares
-
Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study
por: Atti, A., et al.
Publicado: (2022) -
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
por: Hall, Victoria, et al.
Publicado: (2022) -
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023) -
Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies
por: Aguinam, Ernest T., et al.
Publicado: (2023) -
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
por: Cantoni, Diego, et al.
Publicado: (2022)